President Donald Trump has taken aim at the largest U.S. drugmaker for price hikes. More: Trump blasts Pfizer price hikes, pledges a governmental response Source: fierce
read moreSeveral heart drugs containing valsartan are being recalled in Europe and Asia after a Chinese active ingredient manufacturer found residues of a substance that could cause cancer in its supplies. More: EMA recalls heart medicine valsartan made by Chinese firm
read moreMylan has slashed its list price on generic Copaxone, and the move has industry watchers scratching their heads. According to Bernstein analyst Ronny Gal, the company has sunk its sticker to $1,900 per month, well below the $5,000 per month
read moreVertex was already playing hardball with England’s cost-effectiveness watchdogs as price talks for its CF drugs hit yet another impasse last week—and this after its “most innovative and best” offer yet. But CEO Jeffrey Leiden took it to a new
read moreGet ready, cancer drug makers. China is eyeing speedier price cuts on oncology drugs, thanks to an outcry over a movie that publicized smugglers sneaking cheaper generics into the country. And the drugs targeted for cuts are mostly Big Pharma
read moreNHS England has approved routine funding for a stream of new specialised treatments, including stroke-reducing heart implants and a life changing surgical procedure for children with cerebral palsy. More: NHS England clears specialised treatments for NHS use Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals